1. Developmental Biology

Proper migration of lymphatic endothelial cells requires survival and guidance cues from arterial mural cells

  1. Di Peng
  2. Koji Ando  Is a corresponding author
  3. Melina Hußmann
  4. Marleen Gloger
  5. Renae Skoczylas
  6. Naoki Mochizuki.
  7. Christer Betsholtz
  8. Shigetomo Fukuhara
  9. Stefan Schulte-Merker
  10. Nathan D Lawson
  11. Katarzyna Koltowska  Is a corresponding author
  1. Uppsala University, Sweden
  2. Nippon Medical School, Japan
  3. WWU Münster, Germany
  4. National Cerebral and Cardiovascular Center, Japan
  5. University of Massachusetts Medical School, United States
https://doi.org/10.7554/eLife.74094
Share this article
Cite this article
  1. Di Peng
  2. Koji Ando
  3. Melina Hußmann
  4. Marleen Gloger
  5. Renae Skoczylas
  6. Naoki Mochizuki.
  7. Christer Betsholtz
  8. Shigetomo Fukuhara
  9. Stefan Schulte-Merker
  10. Nathan D Lawson
  11. Katarzyna Koltowska
(2022)
Proper migration of lymphatic endothelial cells requires survival and guidance cues from arterial mural cells
eLife 11:e74094.
https://doi.org/10.7554/eLife.74094
  2. Download BibTeX
  3. Download .RIS

Abstract

The migration of lymphatic endothelial cells (LECs) is key for the development of the complex and vast lymphatic vascular network that pervades most tissues in an organism. In zebrafish, arterial intersegmental vessels together with chemokines have been shown to promote lymphatic cell migration from the horizontal myoseptum (HM). We observed that emergence of mural cells around the intersegmental arteries coincides with lymphatic departure from HM which raised the possibility that arterial mural cells promote LEC migration. Our live imaging and cell ablation experiments revealed that LECs migrate slower and fail to establish the lymphatic vascular network in the absence of arterial mural cells. We determined that mural cells are a source for the C-X-C motif chemokine 12 (Cxcl12a and Cxcl12b), Vascular endothelial growth factor C (Vegfc) and Collagen and calcium-binding EGF domain-containing protein 1 (Ccbe1). We showed that chemokine and growth factor signalling function cooperatively to induce robust LEC migration. Specifically, Vegfc-Vegfr3 signalling, but not chemokines, induces extracellular signal-regulated kinase (ERK) activation in LECs, and has an additional pro-survival role in LECs during the migration. Together, the identification of mural cells as a source for signals that guide LEC migration and survival will be important in the future design for rebuilding lymphatic vessels in disease contexts.

Data availability

All data generated or analysed during this study are included in the manuscript and all the source are uploaded

The following previously published data sets were used

Article and author information

Author details

  1. Di Peng

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    The authors declare that no competing interests exist.

  2. Koji Ando

    Department of Molecular Pathophysiology, Nippon Medical School, Kawasaki, Japan
    For correspondence
    koji-ando@nms.ac.jp
    Competing interests
    The authors declare that no competing interests exist.

  3. Melina Hußmann

    Institute of Cardiovascular Organogenesis and Regeneration, WWU Münster, Münster, Germany
    Competing interests
    The authors declare that no competing interests exist.

  4. Marleen Gloger

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3319-7642

  5. Renae Skoczylas

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8570-7368

  6. Naoki Mochizuki.

    Department of Cell Biology, National Cerebral and Cardiovascular Center, Suita, Japan
    Competing interests
    The authors declare that no competing interests exist.

  7. Christer Betsholtz

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    Competing interests
    The authors declare that no competing interests exist.

  8. Shigetomo Fukuhara

    Department of Molecular Pathophysiology, Nippon Medical School, Kawasaki, Japan
    Competing interests
    The authors declare that no competing interests exist.

  9. Stefan Schulte-Merker

    Institute of Cardiovascular Organogenesis and Regeneration, WWU Münster, Münster, Germany
    Competing interests
    The authors declare that no competing interests exist.

  10. Nathan D Lawson

    Department of Molecular, Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7788-9619

  11. Katarzyna Koltowska

    Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
    For correspondence
    kaska.koltowska@igp.uu.se
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6841-8900

Funding

Knut och Alice Wallenbergs Stiftelse (2017.0144)

  • Katarzyna Koltowska

Ragnar Söderbergs stiftelse (M13/17)

  • Katarzyna Koltowska

Vetenskapsrådet (VR-MH-2016-01437)

  • Katarzyna Koltowska

Ragnar Söderbergs stiftelse (M13/17)

  • Di Peng

Jeanssons Stiftelser (n/a)

  • Katarzyna Koltowska

Deutsche Forschungsgemeinschaft (CRC1348B08)

  • Melina Hußmann

Deutsche Forschungsgemeinschaft (CRC1348B08)

  • Stefan Schulte-Merker

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Animal experiments were carried out under ethical approval from the Swedish Board of Agriculture (5.2.18-7558/14).

Copyright

© 2022, Peng et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,940
    views
  • 305
    downloads
  • 9
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Di Peng
  2. Koji Ando
  3. Melina Hußmann
  4. Marleen Gloger
  5. Renae Skoczylas
  6. Naoki Mochizuki.
  7. Christer Betsholtz
  8. Shigetomo Fukuhara
  9. Stefan Schulte-Merker
  10. Nathan D Lawson
  11. Katarzyna Koltowska
(2022)
Proper migration of lymphatic endothelial cells requires survival and guidance cues from arterial mural cells
eLife 11:e74094.
https://doi.org/10.7554/eLife.74094

Share this article

https://doi.org/10.7554/eLife.74094

Categories and tags

Research organism

Further reading

    1. Developmental Biology
    2. Genetics and Genomics

    Determining the effects of paternal obesity on sperm chromatin at histone H3 lysine 4 tri-methylation in relation to the placental transcriptome and cellular composition

    Anne-Sophie Pepin, Patrycja A Jazwiec ... Sarah Kimmins
    Research Article

    Paternal obesity has been implicated in adult-onset metabolic disease in offspring. However, the molecular mechanisms driving these paternal effects and the developmental processes involved remain poorly understood. One underexplored possibility is the role of paternally-induced effects on placenta development and function. To address this, we investigated paternal high-fat diet-induced obesity in relation to sperm histone H3 lysine 4 tri-methylation signatures, the placenta transcriptome and cellular composition. C57BL6/J male mice were fed either a control or high-fat diet for 10 weeks beginning at 6 weeks of age. Males were timed-mated with control-fed C57BL6/J females to generate pregnancies, followed by collection of sperm, and placentas at embryonic day (E)14.5. Chromatin immunoprecipitation targeting histone H3 lysine 4 tri-methylation (H3K4me3) followed by sequencing (ChIP-seq) was performed on sperm to define obesity-associated changes in enrichment. Paternal obesity corresponded with altered sperm H3K4me3 at promoters of genes involved in metabolism and development. Notably, sperm altered H3K4me3 was also localized at placental enhancers. Bulk RNA-sequencing on placentas revealed paternal obesity-associated sex-specific changes in expression of genes involved in hypoxic processes such as angiogenesis, nutrient transport, and imprinted genes, with a subset of deregulated genes showing changes in H3K4me3 in sperm at corresponding promoters. Paternal obesity was also linked to impaired placenta development; specifically, a deconvolution analysis revealed altered trophoblast cell lineage specification. These findings implicate paternal obesity-effects on placenta development and function as one potential developmental route to offspring metabolic disease.

    1. Developmental Biology
    2. Stem Cells and Regenerative Medicine

    Modeling corticotroph deficiency with pituitary organoids supports the functional role of NFKB2 in human pituitary differentiation

    Thi Thom Mac, Teddy Fauquier ... Thierry Brue
    Research Article

    Deficient Anterior pituitary with common Variable Immune Deficiency (DAVID) syndrome results from NFKB2 heterozygous mutations, causing adrenocorticotropic hormone deficiency (ACTHD) and primary hypogammaglobulinemia. While NFKB signaling plays a crucial role in the immune system, its connection to endocrine symptoms is unclear. We established a human disease model to investigate the role of NFKB2 in pituitary development by creating pituitary organoids from CRISPR/Cas9-edited human induced pluripotent stem cells (hiPSCs). Introducing homozygous TBX19K146R/K146R missense pathogenic variant in hiPSC, an allele found in congenital isolated ACTHD, led to a strong reduction of corticotrophs number in pituitary organoids. Then, we characterized the development of organoids harboring NFKB2D865G/D865G mutations found in DAVID patients. NFKB2D865G/D865G mutation acted at different levels of development with mutant organoids displaying changes in the expression of genes involved on pituitary progenitor generation (HESX1, PITX1, LHX3), hypothalamic secreted factors (BMP4, FGF8, FGF10), epithelial-to-mesenchymal transition, lineage precursors development (TBX19, POU1F1) and corticotrophs terminal differentiation (PCSK1, POMC), and showed drastic reduction in the number of corticotrophs. Our results provide strong evidence for the direct role of NFKB2 mutations in the endocrine phenotype observed in patients leading to a new classification of a NFKB2 variant of previously unknown clinical significance as pathogenic in pituitary development.